| 1 |
|
Hair follicles serve as local reservoirs of skin mast cell precursors/
|
Kumamoto, T
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2 |
|
Heat shock protein 70 binds caspase-activated DNase and enhances its activity in TCR-stimulated T cells/
|
Liu, Q.-L
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 3 |
|
Hematopoietic cells for targeting iatrogenic immunomodulation/
|
Nauseef, W. M
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 4 |
|
Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores/
|
Burt, R. K
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 5 |
|
Hematopoietic stimulation by a dipeptidyl peptidase inhibitor reveals a novel regulatory mechanism and therapeutic treatment for blood cell deficiencies/
|
Jones, B
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 6 |
|
Heme and lipid peroxides in hemoglobin-modified low-density lipoprotein mediate cell survival and adaptation to oxidative stress/
|
Asatryan, L
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 7 |
|
Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis/
|
Shibata, J
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 8 |
|
Heparin-induced substrate behavior of antithrombin Cambridge II/
|
Mushunje, A
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 9 |
|
HES and SMCD-eos: birds of a FIP1L1-PDGFRA feather/
|
Mauro, M. J
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 10 |
|
Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin/
|
Miranda, C. J
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 11 |
|
HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro/
|
Ding, S
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 12 |
|
High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis/
|
Nash, R. A
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 13 |
|
High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis/
|
Gopal, A. K
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 14 |
|
High-dose therapy in multiple myeloma/
|
Blade, J
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 15 |
|
High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia/
|
McCarthy, H
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 16 |
|
Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology/
|
Little, R. F
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 17 |
|
High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARalpha expression/
|
Westervelt, P
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 18 |
|
HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen/
|
Radich, J. P
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 19 |
|
HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies/
|
Maris, M. B
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 20 |
|
Homeodomain proteins MEIS1 and PBXs regulate the lineage-specific transcription of the platelet factor 4 gene/
|
Okada, Y
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|